カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のレボチロキシンナトリウム錠市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Levothyroxine Sodium Tablet Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19719）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19719
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：105
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のレボチロキシンナトリウム錠市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

レボチロキシンナトリウム錠市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のレボチロキシンナトリウム錠の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

レボチロキシンナトリウム錠市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・0.1mg、0.125mg、0.2mg、その他

用途別セグメントは次のように区分されます。
・病院、薬局、その他

世界のレボチロキシンナトリウム錠市場の主要な市場プレーヤーは以下のとおりです。
・Abbvie、Mylan Pharma、Merck、Pfizer、Lannett Company、Novartis、Fresenius Kabi、IBSA、Piramal Critical Care、Abbott

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、レボチロキシンナトリウム錠製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なレボチロキシンナトリウム錠メーカーの企業概要、2019年～2022年までのレボチロキシンナトリウム錠の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なレボチロキシンナトリウム錠メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別レボチロキシンナトリウム錠の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのレボチロキシンナトリウム錠の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのレボチロキシンナトリウム錠市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびレボチロキシンナトリウム錠の産業チェーンを掲載しています。
・第13、14、15章では、レボチロキシンナトリウム錠の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- レボチロキシンナトリウム錠の概要
- 種類別分析（2017年vs2021年vs2028年）：0.1mg、0.125mg、0.2mg、その他
- 用途別分析（2017年vs2021年vs2028年）：病院、薬局、その他
- 世界のレボチロキシンナトリウム錠市場規模・予測
- 世界のレボチロキシンナトリウム錠生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Abbvie、Mylan Pharma、Merck、Pfizer、Lannett Company、Novartis、Fresenius Kabi、IBSA、Piramal Critical Care、Abbott
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：0.1mg、0.125mg、0.2mg、その他
・用途別分析2017年-2028年：病院、薬局、その他
・レボチロキシンナトリウム錠の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・レボチロキシンナトリウム錠のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・レボチロキシンナトリウム錠のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・レボチロキシンナトリウム錠の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・レボチロキシンナトリウム錠の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Levothyroxine Sodium Tablet market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Levothyroxine Sodium Tablet market size is estimated to be worth US$ 3708.5 million in 2021 and is forecast to a readjusted size of USD 4445.2 million by 2028 with a CAGR of 2.6% during review period. Hospitals accounting for % of the Levothyroxine Sodium Tablet global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 0.1 mg segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Levothyroxine Sodium Tablet include Abbvie, Mylan Pharma, Merck, Pfizer, and Lannett Company, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Levothyroxine Sodium Tablet market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
0.1 mg
0.125 mg
0.2 mg
Others
Market segment by Application can be divided into
Hospitals
Pharmacy
Others
The key market players for global Levothyroxine Sodium Tablet market are listed below:
Abbvie
Mylan Pharma
Merck
Pfizer
Lannett Company
Novartis
Fresenius Kabi
IBSA
Piramal Critical Care
Abbott
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Levothyroxine Sodium Tablet product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Levothyroxine Sodium Tablet, with price, sales, revenue and global market share of Levothyroxine Sodium Tablet from 2019 to 2022.
Chapter 3, the Levothyroxine Sodium Tablet competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Levothyroxine Sodium Tablet breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Levothyroxine Sodium Tablet market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Levothyroxine Sodium Tablet.
Chapter 13, 14, and 15, to describe Levothyroxine Sodium Tablet sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Levothyroxine Sodium Tablet Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Levothyroxine Sodium Tablet Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 0.1 mg
1.2.3 0.125 mg
1.2.4 0.2 mg
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Levothyroxine Sodium Tablet Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Pharmacy
1.3.4 Others
1.4 Global Levothyroxine Sodium Tablet Market Size & Forecast
1.4.1 Global Levothyroxine Sodium Tablet Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Levothyroxine Sodium Tablet Sales in Volume (2017-2028)
1.4.3 Global Levothyroxine Sodium Tablet Price (2017-2028)
1.5 Global Levothyroxine Sodium Tablet Production Capacity Analysis
1.5.1 Global Levothyroxine Sodium Tablet Total Production Capacity (2017-2028)
1.5.2 Global Levothyroxine Sodium Tablet Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Levothyroxine Sodium Tablet Market Drivers
1.6.2 Levothyroxine Sodium Tablet Market Restraints
1.6.3 Levothyroxine Sodium Tablet Trends Analysis
2 Manufacturers Profiles
2.1 Abbvie
2.1.1 Abbvie Details
2.1.2 Abbvie Major Business
2.1.3 Abbvie Levothyroxine Sodium Tablet Product and Services
2.1.4 Abbvie Levothyroxine Sodium Tablet Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Mylan Pharma
2.2.1 Mylan Pharma Details
2.2.2 Mylan Pharma Major Business
2.2.3 Mylan Pharma Levothyroxine Sodium Tablet Product and Services
2.2.4 Mylan Pharma Levothyroxine Sodium Tablet Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Levothyroxine Sodium Tablet Product and Services
2.3.4 Merck Levothyroxine Sodium Tablet Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Levothyroxine Sodium Tablet Product and Services
2.4.4 Pfizer Levothyroxine Sodium Tablet Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Lannett Company
2.5.1 Lannett Company Details
2.5.2 Lannett Company Major Business
2.5.3 Lannett Company Levothyroxine Sodium Tablet Product and Services
2.5.4 Lannett Company Levothyroxine Sodium Tablet Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Levothyroxine Sodium Tablet Product and Services
2.6.4 Novartis Levothyroxine Sodium Tablet Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Fresenius Kabi
2.7.1 Fresenius Kabi Details
2.7.2 Fresenius Kabi Major Business
2.7.3 Fresenius Kabi Levothyroxine Sodium Tablet Product and Services
2.7.4 Fresenius Kabi Levothyroxine Sodium Tablet Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 IBSA
2.8.1 IBSA Details
2.8.2 IBSA Major Business
2.8.3 IBSA Levothyroxine Sodium Tablet Product and Services
2.8.4 IBSA Levothyroxine Sodium Tablet Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Piramal Critical Care
2.9.1 Piramal Critical Care Details
2.9.2 Piramal Critical Care Major Business
2.9.3 Piramal Critical Care Levothyroxine Sodium Tablet Product and Services
2.9.4 Piramal Critical Care Levothyroxine Sodium Tablet Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Abbott
2.10.1 Abbott Details
2.10.2 Abbott Major Business
2.10.3 Abbott Levothyroxine Sodium Tablet Product and Services
2.10.4 Abbott Levothyroxine Sodium Tablet Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Levothyroxine Sodium Tablet Breakdown Data by Manufacturer
3.1 Global Levothyroxine Sodium Tablet Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Levothyroxine Sodium Tablet Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Levothyroxine Sodium Tablet
3.4 Market Concentration Rate
3.4.1 Top 3 Levothyroxine Sodium Tablet Manufacturer Market Share in 2021
3.4.2 Top 6 Levothyroxine Sodium Tablet Manufacturer Market Share in 2021
3.5 Global Levothyroxine Sodium Tablet Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Levothyroxine Sodium Tablet Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Levothyroxine Sodium Tablet Market Size by Region
4.1.1 Global Levothyroxine Sodium Tablet Sales in Volume by Region (2017-2028)
4.1.2 Global Levothyroxine Sodium Tablet Revenue by Region (2017-2028)
4.2 North America Levothyroxine Sodium Tablet Revenue (2017-2028)
4.3 Europe Levothyroxine Sodium Tablet Revenue (2017-2028)
4.4 Asia-Pacific Levothyroxine Sodium Tablet Revenue (2017-2028)
4.5 South America Levothyroxine Sodium Tablet Revenue (2017-2028)
4.6 Middle East and Africa Levothyroxine Sodium Tablet Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Levothyroxine Sodium Tablet Sales in Volume by Type (2017-2028)
5.2 Global Levothyroxine Sodium Tablet Revenue by Type (2017-2028)
5.3 Global Levothyroxine Sodium Tablet Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Levothyroxine Sodium Tablet Sales in Volume by Application (2017-2028)
6.2 Global Levothyroxine Sodium Tablet Revenue by Application (2017-2028)
6.3 Global Levothyroxine Sodium Tablet Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Levothyroxine Sodium Tablet Sales by Type (2017-2028)
7.2 North America Levothyroxine Sodium Tablet Sales by Application (2017-2028)
7.3 North America Levothyroxine Sodium Tablet Market Size by Country
7.3.1 North America Levothyroxine Sodium Tablet Sales in Volume by Country (2017-2028)
7.3.2 North America Levothyroxine Sodium Tablet Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Levothyroxine Sodium Tablet Sales by Type (2017-2028)
8.2 Europe Levothyroxine Sodium Tablet Sales by Application (2017-2028)
8.3 Europe Levothyroxine Sodium Tablet Market Size by Country
8.3.1 Europe Levothyroxine Sodium Tablet Sales in Volume by Country (2017-2028)
8.3.2 Europe Levothyroxine Sodium Tablet Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Levothyroxine Sodium Tablet Sales by Type (2017-2028)
9.2 Asia-Pacific Levothyroxine Sodium Tablet Sales by Application (2017-2028)
9.3 Asia-Pacific Levothyroxine Sodium Tablet Market Size by Region
9.3.1 Asia-Pacific Levothyroxine Sodium Tablet Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Levothyroxine Sodium Tablet Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Levothyroxine Sodium Tablet Sales by Type (2017-2028)
10.2 South America Levothyroxine Sodium Tablet Sales by Application (2017-2028)
10.3 South America Levothyroxine Sodium Tablet Market Size by Country
10.3.1 South America Levothyroxine Sodium Tablet Sales in Volume by Country (2017-2028)
10.3.2 South America Levothyroxine Sodium Tablet Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Levothyroxine Sodium Tablet Sales by Type (2017-2028)
11.2 Middle East & Africa Levothyroxine Sodium Tablet Sales by Application (2017-2028)
11.3 Middle East & Africa Levothyroxine Sodium Tablet Market Size by Country
11.3.1 Middle East & Africa Levothyroxine Sodium Tablet Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Levothyroxine Sodium Tablet Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Levothyroxine Sodium Tablet and Key Manufacturers
12.2 Manufacturing Costs Percentage of Levothyroxine Sodium Tablet
12.3 Levothyroxine Sodium Tablet Production Process
12.4 Levothyroxine Sodium Tablet Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Levothyroxine Sodium Tablet Typical Distributors
13.3 Levothyroxine Sodium Tablet Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Levothyroxine Sodium Tablet Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Levothyroxine Sodium Tablet Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Abbvie Basic Information, Manufacturing Base and Competitors
Table 4. Abbvie Major Business
Table 5. Abbvie Levothyroxine Sodium Tablet Product and Services
Table 6. Abbvie Levothyroxine Sodium Tablet Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Mylan Pharma Basic Information, Manufacturing Base and Competitors
Table 8. Mylan Pharma Major Business
Table 9. Mylan Pharma Levothyroxine Sodium Tablet Product and Services
Table 10. Mylan Pharma Levothyroxine Sodium Tablet Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Merck Basic Information, Manufacturing Base and Competitors
Table 12. Merck Major Business
Table 13. Merck Levothyroxine Sodium Tablet Product and Services
Table 14. Merck Levothyroxine Sodium Tablet Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Pfizer Basic Information, Manufacturing Base and Competitors
Table 16. Pfizer Major Business
Table 17. Pfizer Levothyroxine Sodium Tablet Product and Services
Table 18. Pfizer Levothyroxine Sodium Tablet Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Lannett Company Basic Information, Manufacturing Base and Competitors
Table 20. Lannett Company Major Business
Table 21. Lannett Company Levothyroxine Sodium Tablet Product and Services
Table 22. Lannett Company Levothyroxine Sodium Tablet Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Novartis Basic Information, Manufacturing Base and Competitors
Table 24. Novartis Major Business
Table 25. Novartis Levothyroxine Sodium Tablet Product and Services
Table 26. Novartis Levothyroxine Sodium Tablet Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 28. Fresenius Kabi Major Business
Table 29. Fresenius Kabi Levothyroxine Sodium Tablet Product and Services
Table 30. Fresenius Kabi Levothyroxine Sodium Tablet Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. IBSA Basic Information, Manufacturing Base and Competitors
Table 32. IBSA Major Business
Table 33. IBSA Levothyroxine Sodium Tablet Product and Services
Table 34. IBSA Levothyroxine Sodium Tablet Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Piramal Critical Care Basic Information, Manufacturing Base and Competitors
Table 36. Piramal Critical Care Major Business
Table 37. Piramal Critical Care Levothyroxine Sodium Tablet Product and Services
Table 38. Piramal Critical Care Levothyroxine Sodium Tablet Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Abbott Basic Information, Manufacturing Base and Competitors
Table 40. Abbott Major Business
Table 41. Abbott Levothyroxine Sodium Tablet Product and Services
Table 42. Abbott Levothyroxine Sodium Tablet Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Global Levothyroxine Sodium Tablet Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 44. Global Levothyroxine Sodium Tablet Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 45. Market Position of Manufacturers in Levothyroxine Sodium Tablet, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 46. Global Levothyroxine Sodium Tablet Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Levothyroxine Sodium Tablet Production Site of Key Manufacturer
Table 48. Levothyroxine Sodium Tablet New Entrant and Capacity Expansion Plans
Table 49. Levothyroxine Sodium Tablet Mergers & Acquisitions in the Past Five Years
Table 50. Global Levothyroxine Sodium Tablet Sales by Region (2017-2022) & (K Units)
Table 51. Global Levothyroxine Sodium Tablet Sales by Region (2023-2028) & (K Units)
Table 52. Global Levothyroxine Sodium Tablet Revenue by Region (2017-2022) & (USD Million)
Table 53. Global Levothyroxine Sodium Tablet Revenue by Region (2023-2028) & (USD Million)
Table 54. Global Levothyroxine Sodium Tablet Sales by Type (2017-2022) & (K Units)
Table 55. Global Levothyroxine Sodium Tablet Sales by Type (2023-2028) & (K Units)
Table 56. Global Levothyroxine Sodium Tablet Revenue by Type (2017-2022) & (USD Million)
Table 57. Global Levothyroxine Sodium Tablet Revenue by Type (2023-2028) & (USD Million)
Table 58. Global Levothyroxine Sodium Tablet Price by Type (2017-2022) & (US$/Unit)
Table 59. Global Levothyroxine Sodium Tablet Price by Type (2023-2028) & (US$/Unit)
Table 60. Global Levothyroxine Sodium Tablet Sales by Application (2017-2022) & (K Units)
Table 61. Global Levothyroxine Sodium Tablet Sales by Application (2023-2028) & (K Units)
Table 62. Global Levothyroxine Sodium Tablet Revenue by Application (2017-2022) & (USD Million)
Table 63. Global Levothyroxine Sodium Tablet Revenue by Application (2023-2028) & (USD Million)
Table 64. Global Levothyroxine Sodium Tablet Price by Application (2017-2022) & (US$/Unit)
Table 65. Global Levothyroxine Sodium Tablet Price by Application (2023-2028) & (US$/Unit)
Table 66. North America Levothyroxine Sodium Tablet Sales by Country (2017-2022) & (K Units)
Table 67. North America Levothyroxine Sodium Tablet Sales by Country (2023-2028) & (K Units)
Table 68. North America Levothyroxine Sodium Tablet Revenue by Country (2017-2022) & (USD Million)
Table 69. North America Levothyroxine Sodium Tablet Revenue by Country (2023-2028) & (USD Million)
Table 70. North America Levothyroxine Sodium Tablet Sales by Type (2017-2022) & (K Units)
Table 71. North America Levothyroxine Sodium Tablet Sales by Type (2023-2028) & (K Units)
Table 72. North America Levothyroxine Sodium Tablet Sales by Application (2017-2022) & (K Units)
Table 73. North America Levothyroxine Sodium Tablet Sales by Application (2023-2028) & (K Units)
Table 74. Europe Levothyroxine Sodium Tablet Sales by Country (2017-2022) & (K Units)
Table 75. Europe Levothyroxine Sodium Tablet Sales by Country (2023-2028) & (K Units)
Table 76. Europe Levothyroxine Sodium Tablet Revenue by Country (2017-2022) & (USD Million)
Table 77. Europe Levothyroxine Sodium Tablet Revenue by Country (2023-2028) & (USD Million)
Table 78. Europe Levothyroxine Sodium Tablet Sales by Type (2017-2022) & (K Units)
Table 79. Europe Levothyroxine Sodium Tablet Sales by Type (2023-2028) & (K Units)
Table 80. Europe Levothyroxine Sodium Tablet Sales by Application (2017-2022) & (K Units)
Table 81. Europe Levothyroxine Sodium Tablet Sales by Application (2023-2028) & (K Units)
Table 82. Asia-Pacific Levothyroxine Sodium Tablet Sales by Region (2017-2022) & (K Units)
Table 83. Asia-Pacific Levothyroxine Sodium Tablet Sales by Region (2023-2028) & (K Units)
Table 84. Asia-Pacific Levothyroxine Sodium Tablet Revenue by Region (2017-2022) & (USD Million)
Table 85. Asia-Pacific Levothyroxine Sodium Tablet Revenue by Region (2023-2028) & (USD Million)
Table 86. Asia-Pacific Levothyroxine Sodium Tablet Sales by Type (2017-2022) & (K Units)
Table 87. Asia-Pacific Levothyroxine Sodium Tablet Sales by Type (2023-2028) & (K Units)
Table 88. Asia-Pacific Levothyroxine Sodium Tablet Sales by Application (2017-2022) & (K Units)
Table 89. Asia-Pacific Levothyroxine Sodium Tablet Sales by Application (2023-2028) & (K Units)
Table 90. South America Levothyroxine Sodium Tablet Sales by Country (2017-2022) & (K Units)
Table 91. South America Levothyroxine Sodium Tablet Sales by Country (2023-2028) & (K Units)
Table 92. South America Levothyroxine Sodium Tablet Revenue by Country (2017-2022) & (USD Million)
Table 93. South America Levothyroxine Sodium Tablet Revenue by Country (2023-2028) & (USD Million)
Table 94. South America Levothyroxine Sodium Tablet Sales by Type (2017-2022) & (K Units)
Table 95. South America Levothyroxine Sodium Tablet Sales by Type (2023-2028) & (K Units)
Table 96. South America Levothyroxine Sodium Tablet Sales by Application (2017-2022) & (K Units)
Table 97. South America Levothyroxine Sodium Tablet Sales by Application (2023-2028) & (K Units)
Table 98. Middle East & Africa Levothyroxine Sodium Tablet Sales by Region (2017-2022) & (K Units)
Table 99. Middle East & Africa Levothyroxine Sodium Tablet Sales by Region (2023-2028) & (K Units)
Table 100. Middle East & Africa Levothyroxine Sodium Tablet Revenue by Region (2017-2022) & (USD Million)
Table 101. Middle East & Africa Levothyroxine Sodium Tablet Revenue by Region (2023-2028) & (USD Million)
Table 102. Middle East & Africa Levothyroxine Sodium Tablet Sales by Type (2017-2022) & (K Units)
Table 103. Middle East & Africa Levothyroxine Sodium Tablet Sales by Type (2023-2028) & (K Units)
Table 104. Middle East & Africa Levothyroxine Sodium Tablet Sales by Application (2017-2022) & (K Units)
Table 105. Middle East & Africa Levothyroxine Sodium Tablet Sales by Application (2023-2028) & (K Units)
Table 106. Levothyroxine Sodium Tablet Raw Material
Table 107. Key Manufacturers of Levothyroxine Sodium Tablet Raw Materials
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Levothyroxine Sodium Tablet Typical Distributors
Table 111. Levothyroxine Sodium Tablet Typical Customers
List of Figures
Figure 1. Levothyroxine Sodium Tablet Picture
Figure 2. Global Levothyroxine Sodium Tablet Revenue Market Share by Type in 2021
Figure 3. 0.1 mg
Figure 4. 0.125 mg
Figure 5. 0.2 mg
Figure 6. Others
Figure 7. Global Levothyroxine Sodium Tablet Revenue Market Share by Application in 2021
Figure 8. Hospitals
Figure 9. Pharmacy
Figure 10. Others
Figure 11. Global Levothyroxine Sodium Tablet Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 12. Global Levothyroxine Sodium Tablet Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Levothyroxine Sodium Tablet Sales (2017-2028) & (K Units)
Figure 14. Global Levothyroxine Sodium Tablet Price (2017-2028) & (US$/Unit)
Figure 15. Global Levothyroxine Sodium Tablet Production Capacity (2017-2028) & (K Units)
Figure 16. Global Levothyroxine Sodium Tablet Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Levothyroxine Sodium Tablet Market Drivers
Figure 18. Levothyroxine Sodium Tablet Market Restraints
Figure 19. Levothyroxine Sodium Tablet Market Trends
Figure 20. Global Levothyroxine Sodium Tablet Sales Market Share by Manufacturer in 2021
Figure 21. Global Levothyroxine Sodium Tablet Revenue Market Share by Manufacturer in 2021
Figure 22. Levothyroxine Sodium Tablet Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Levothyroxine Sodium Tablet Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Levothyroxine Sodium Tablet Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Levothyroxine Sodium Tablet Sales Market Share by Region (2017-2028)
Figure 26. Global Levothyroxine Sodium Tablet Revenue Market Share by Region (2017-2028)
Figure 27. North America Levothyroxine Sodium Tablet Revenue (2017-2028) & (USD Million)
Figure 28. Europe Levothyroxine Sodium Tablet Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Levothyroxine Sodium Tablet Revenue (2017-2028) & (USD Million)
Figure 30. South America Levothyroxine Sodium Tablet Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Levothyroxine Sodium Tablet Revenue (2017-2028) & (USD Million)
Figure 32. Global Levothyroxine Sodium Tablet Sales Market Share by Type (2017-2028)
Figure 33. Global Levothyroxine Sodium Tablet Revenue Market Share by Type (2017-2028)
Figure 34. Global Levothyroxine Sodium Tablet Price by Type (2017-2028) & (US$/Unit)
Figure 35. Global Levothyroxine Sodium Tablet Sales Market Share by Application (2017-2028)
Figure 36. Global Levothyroxine Sodium Tablet Revenue Market Share by Application (2017-2028)
Figure 37. Global Levothyroxine Sodium Tablet Price by Application (2017-2028) & (US$/Unit)
Figure 38. North America Levothyroxine Sodium Tablet Sales Market Share by Type (2017-2028)
Figure 39. North America Levothyroxine Sodium Tablet Sales Market Share by Application (2017-2028)
Figure 40. North America Levothyroxine Sodium Tablet Sales Market Share by Country (2017-2028)
Figure 41. North America Levothyroxine Sodium Tablet Revenue Market Share by Country (2017-2028)
Figure 42. United States Levothyroxine Sodium Tablet Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Levothyroxine Sodium Tablet Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Levothyroxine Sodium Tablet Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Levothyroxine Sodium Tablet Sales Market Share by Type (2017-2028)
Figure 46. Europe Levothyroxine Sodium Tablet Sales Market Share by Application (2017-2028)
Figure 47. Europe Levothyroxine Sodium Tablet Sales Market Share by Country (2017-2028)
Figure 48. Europe Levothyroxine Sodium Tablet Revenue Market Share by Country (2017-2028)
Figure 49. Germany Levothyroxine Sodium Tablet Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Levothyroxine Sodium Tablet Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Levothyroxine Sodium Tablet Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Levothyroxine Sodium Tablet Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Levothyroxine Sodium Tablet Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Levothyroxine Sodium Tablet Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Levothyroxine Sodium Tablet Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Levothyroxine Sodium Tablet Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Levothyroxine Sodium Tablet Revenue Market Share by Region (2017-2028)
Figure 58. China Levothyroxine Sodium Tablet Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Levothyroxine Sodium Tablet Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Levothyroxine Sodium Tablet Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Levothyroxine Sodium Tablet Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Levothyroxine Sodium Tablet Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Levothyroxine Sodium Tablet Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Levothyroxine Sodium Tablet Sales Market Share by Type (2017-2028)
Figure 65. South America Levothyroxine Sodium Tablet Sales Market Share by Application (2017-2028)
Figure 66. South America Levothyroxine Sodium Tablet Sales Market Share by Country (2017-2028)
Figure 67. South America Levothyroxine Sodium Tablet Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Levothyroxine Sodium Tablet Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Levothyroxine Sodium Tablet Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Levothyroxine Sodium Tablet Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Levothyroxine Sodium Tablet Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Levothyroxine Sodium Tablet Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Levothyroxine Sodium Tablet Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Levothyroxine Sodium Tablet Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Levothyroxine Sodium Tablet Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Levothyroxine Sodium Tablet Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Levothyroxine Sodium Tablet Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Levothyroxine Sodium Tablet in 2021
Figure 79. Manufacturing Process Analysis of Levothyroxine Sodium Tablet
Figure 80. Levothyroxine Sodium Tablet Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の注射用レボチロキシンナトリウム市場2022年：市場規模予測（～2028年）
  • 世界の経口用レボチロキシンナトリウム市場2022年：市場規模予測（～2028年）
  • 世界のデフェラシロックス錠市場2022年：市場規模予測（～2028年）
  • 世界のチニダゾール錠市場2022年：市場規模予測（～2028年）
  • 世界のブリガチニブ錠市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19719 )"世界のレボチロキシンナトリウム錠市場2022年：市場規模予測（～2028年）" (英文：Global Levothyroxine Sodium Tablet Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。